No Data
No Data
Changjiang Pharmaceutical Group (300391.SZ): Received a letter from the independent director urging action.
Changjiang Pharmaceutical Group (300391.SZ) announced that they have received a supervision letter jointly submitted by independent directors Mr. Deng Yuanjun, Ms. Lan Xia, and Mr. Wu Kangbing regarding the promotion of self-examination and correction and relevant work of Changjiang Pharmaceutical.
Express News | Changyao Holdings: Director, Deputy General Manager and Board Secretary Ning Luhong resigns
Changyao Holdings (300391.SZ) announced first-quarter results with a net loss of 47.5059 million yuan, an increase of 106.92%
According to the Zhitong Finance App, Changyao Holdings (300391.SZ) released its report for the first quarter of 2024. The company's revenue was 59.9018 million yuan, a year-on-year decrease of 56.80%. The net loss attributable to shareholders of listed companies was 47.5059 million yuan, an increase of 106.92% over the previous year. Net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 456.596 million, an increase of 97.65% over the previous year. The basic loss per share was $0.1356.
Changyao Holdings (300391.SZ): Chairman Li Jinfeng resigns
On March 15, Gelonghui | Changyao Holdings (300391.SZ) announced that it received a written “resignation” from Chairman Li Jinfeng. Due to personal reasons, Ms. Li Jinfeng resigned as chairman and director of the 5th board of directors of the company. After her resignation, she did not hold any positions in the company or its subsidiaries. As of the disclosure date of this announcement, Ms. Li Jinfeng did not hold shares in the company.
Changyao Holdings (300391.SZ): No notice was received from the company's shareholders regarding the risk of pledge settlement
Gelonghui, Feb. 6 | Changyao Holdings (300391.SZ) said on the investor interactive platform that candidates for the company's new general manager are being selected, and after determining the right person, the company will submit them to the company's board of directors to carry out the appointment approval process. Currently, the company has not received any notice from the company's shareholders relating to the risk of pledge settlement.
Changyao Holdings (300391.SZ): Pre-loss of 500 million yuan to 700 million yuan in 2023
Gelonghui, January 30, 丨 Changyao Holdings (300391.SZ) announced its 2023 annual results forecast. Net profit loss attributable to shareholders of listed companies during the reporting period was 50 million yuan to 70 million yuan, loss of 23.2733 million yuan for the same period of the previous year; net profit loss after deducting non-recurring profit and loss of 575 million yuan to 775 million yuan, loss of 76.3948 million yuan for the same period last year; operating income of 110,000 yuan to 130,000 yuan after deduction . In 2023, to promote
No Data